Improved survival outcome of curative liver resection for Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma in the era of tyrosine kinase inhibitors.

Yoh Asahi Tatsuhiko KakisakaToshiya KamiyamaTatsuya OrimoShingo ShimadaAkihisa NagatsuTakeshi Aiyama Yuzuru Sakamoto Kazuki Wakizaka Shunsuke ShichiHirofumi KamachiAkinobu Taketomi

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2024)

These data suggest that TKI therapy for recurrent BCLC-C HCC is associated with improved overall survival. Thus, LR could be a promising option for BCLC-C HCC in the current era of TKI therapy.

Keyphrases

chronic myeloid leukemia
tyrosine kinase
advanced non small cell lung cancer
primary care
electronic health record
big data
prognostic factors
bone marrow
mesenchymal stem cells
data analysis